Skip to main content
SpringerLink
Log in

Erythropoietin and Analogs

  • Chapter
  • First Online:
Doping in Sports: Biochemical Principles, Effects and Analysis

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 195))

Abstract

Erythropoietin (EPO), a glycoprotein hormone, stimulates the growth of red blood cells and as a consequence it increases tissue oxygenation. This performance enhancing effect is responsible for the ban of erythropioetin in sports since 1990. Especially its recombinant synthesis led to the abuse of this hormone, predominatly in endurance sports. The analytical differentiation of endogenously produced erythropoietin from its recombinant counterpart by using isoelectric focusing and double blotting is a milestone in the detection of doping with recombinant erythropoietin. However, various analogous of the initial recombinant products, not always easily detectable by the standard IEF-method, necessitate the development of analytical alternatives for the detection of EPO doping. The following chapter summarizes its mode of action, the various forms of recombinant erythropoietin, the main analytical procedures and strategies for the detection of EPO doping as well as a typical case report.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abellan R et al (2007) Intermittent hypoxia exposure in a hypobaric chamber and erythropoietin abuse interpretation. J Sports Sci 25(11):1241–1250

    Article  PubMed  Google Scholar 

  • Aktories K et al (2005) Allgemeine und spezielle Pharmakologie. Urban & Fischer, München

    Google Scholar 

  • Ashenden MJ et al (2003) Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88(9):1053–1062

    PubMed  Google Scholar 

  • Ashenden MJ et al (2004) Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes. Haematologica 89(8):1019–1020

    CAS  PubMed  Google Scholar 

  • Ashenden MJ et al (2006) The effects of microdose recombinant human erythropoietin regimens in athletes. Haematologica 91(8):1143–1144

    CAS  PubMed  Google Scholar 

  • Audran M et al (1999) Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc 31(5):639–645

    Article  CAS  PubMed  Google Scholar 

  • Bajla I et al (2001) Quantitative analysis of images in erythropoietin doping control. Med Biol Eng Comput 43(3):403–409

    Article  Google Scholar 

  • Bajla I et al (2005) GASepo – a software solution for quantitative analysis of digital images in Epo doping control. Comput Methods Programs Biomed 80(3):246–270

    Article  CAS  PubMed  Google Scholar 

  • Balaguer E, Neusüss C (2006a) Glycoprotein characterization combining intact protein and glycan analysis by capillary electrophoresis-electrospray ionization-mass spectrometry. Anal Chem 78(15):5384–5393

    Article  CAS  PubMed  Google Scholar 

  • Balaguer E, Neusüss C (2006b) Intact glycoform characterization of erythropoietin-alfa and erythropoietin-beta by CZE-ESI-TOF-MS. Chromatographia 64:351–357

    Article  CAS  Google Scholar 

  • Balaguer E et al (2006) Glycoform characterization of erythropoietin combining glycan and intact protein analysis by capillary electrophoresis–electrospray – time-of-flight mass spectrometry. Electrophoresis 27(13):2638–2650

    Article  CAS  PubMed  Google Scholar 

  • Balsom PD et al (1994) Enhanced oxygen availability during high intensity intermittent exercise decreases anaerobic metabolite concentration in blood. Acta Physiol Scand 150:455–456

    Article  CAS  PubMed  Google Scholar 

  • Barbone FP et al (1997) Mutagenesis studies of the human erythropoietin receptor. Establishment of structure–function relationships. J Biol Chem 272:4985–4992

    Article  CAS  PubMed  Google Scholar 

  • Barroso O et al (2008) Hormone abuse in sports: the antidoping perspective. Asian J Androl 10(3):391–402

    Article  CAS  PubMed  Google Scholar 

  • Bartlett C et al (2006) Detection of the administration of human erythropoietin (HuEPO) to canines. J Anal Toxicol 30(9):663–669

    CAS  PubMed  Google Scholar 

  • Belalcazar V et al (2006) Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine. Electrophoresis 27(22):4387–4395

    Article  CAS  PubMed  Google Scholar 

  • Berglund B (2002) Blood doping–a short background. In: Bowers L, Shymanski E (eds) Oxygen transport enhancing agents and methods, 1st edn. United States Anti-Doping Agency, Colorado Springs

    Google Scholar 

  • Berglund B, Wide L (2002) Erythropoietin concentrations and isoforms in urine of anonymous Olympic athletes during the Nagano Olympic Games. Scand J Med Sci Sports 12(6):354–357

    Article  CAS  PubMed  Google Scholar 

  • Berglund B et al (2003) Effect of short-term and intermittent normobaric hypoxia on endogenous erythropoietin isoforms. Scand J Med Sci Sports 13(2):124–127

    Article  CAS  PubMed  Google Scholar 

  • Beullens M et al (2006) False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood 107(12):4711–4713

    Article  CAS  PubMed  Google Scholar 

  • Bonsdorff E, Jalavisto E (1948) A humoral mechanism in anoxic erythrocytosis. Acta Physiol Scand 16:150–170

    Article  CAS  Google Scholar 

  • Breidbach A et al (2003) Detection of recombinant human erythropoietin in urine by isoelectric focusing. Clin Chem 49(6):901–907

    Article  CAS  PubMed  Google Scholar 

  • Bressolle F et al (1997) Population pharmacodynamics for monitoring epoetin in athletes. Clin Drug Invest 14:233–242

    Article  CAS  Google Scholar 

  • Bunn HF (2007) New agents that stimulate erythropoiesis. Blood 109(3):868–873

    Article  CAS  PubMed  Google Scholar 

  • Caldini A et al (2001) Epoetin alpha, epoetin beta and darbepoetin alfa: two-dimensional gel electrophoresis isoforms characterization and mass spectrometry analysis. Proteomics 3(6):937–941

    Article  CAS  Google Scholar 

  • Catlin DH et al (2003) Abuse of recombinant erythropoietins by athletes. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Cheetham JC et al (1998) NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat Struct Biol 5:861–866

    Article  CAS  PubMed  Google Scholar 

  • Choi D et al (1996) Erythropoietin: physico- and biochemical analysis. J Chromatogr B Biomed Appl 687(1):189–199

    Article  CAS  PubMed  Google Scholar 

  • Chuck AS et al (2003) Commercial production of recombinant erythropoietins. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Cushner FD (2003) Use of erythropoietins in surgical settings. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Dame C (2003) Molecular biology of the erythropoietin receptor in hematopoietic and non-hematopoietic tissues. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Davis JM et al (1987) Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry 26:2633–2638

    Article  CAS  PubMed  Google Scholar 

  • De Frutos M et al (2003) Differences in capillary electrophoresis profiles of urinary and recombinant erythropoietin. Electrophoresis 24(4):678–680

    Article  PubMed  Google Scholar 

  • Deicher R, Hörl WH (2004) Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease. Drugs 64(5):499–509

    Article  CAS  PubMed  Google Scholar 

  • Delanghe JR et al (2008) Testing for recombinant erythropoietin. Am J Hematol 83(3):237–241

    Article  CAS  PubMed  Google Scholar 

  • DeLano WL (2007) The PyMOL Molecular Graphics System. DeLano Scientific LLC, Palo Alto, CA, USA. http://www.pymol.org

  • Desharnais P and Ayotte C (2007) Towards the screening of urinary Epo by SDS-PAGE analysis. In: Schänzer et al (ed) Recent advances in doping analysis (15), Sportverlag Strauss, Cologne

    Google Scholar 

  • Donati A (2005) World trafficking of doping substanzes. http://www.wada-ama.org/rtecontent/document/Donati_Report_Trafficking_2007-03_06.pdf. Cited 16 August 2008

  • Dou P, Liu Z, He J, Xu JJ, Chen HY (2008) Rapid and high-resolution glycoform profiling of recombinant human erythropoietin by capillary isoelectric focusing with whole column imaging detection. J Chromatogr A 1190(1–2):372–376

    Article  CAS  PubMed  Google Scholar 

  • Eagleton HJ, Littlewood TJ (2003) Update on the clinical use and misuse of erythropoietin. Curr Hematol Rep 2(2):109–115

    PubMed  Google Scholar 

  • Ebert BL, Bunn HF (1999) Regulation of the erythropoietin gene. Blood 74:1864–1877

    Google Scholar 

  • Egrie JC, Browne JK (2001) Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 16(3):3–13

    PubMed  Google Scholar 

  • Egrie JC et al (1993) The role of carbohydrate on the biological activity of erythropoietin. Glycoconjugate J 10:263

    Article  Google Scholar 

  • Eichner ER (2007) Blood doping: infusions, erythropoietin and artificial blood. Sports Med 37(4–5):389–391

    Article  PubMed  Google Scholar 

  • Ekblom BT (2000) Blood boosting and sport. Baillieres Best Pract Res Clin Endocrinol Metab 14(1):89–98

    Article  CAS  PubMed  Google Scholar 

  • Ekblom B, Berglund B (1991) Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports 1:88–93

    Article  Google Scholar 

  • Ekblom B et al (1972) Response to exercise after blood loss and reinfusion. J Appl Physiol 40:175–180

    Google Scholar 

  • Elliott SG (2003) New molecules and formulations of recombinant human erythropoietin. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Elliott SG et al (2004) Control of rHuEPO biological activity: the role of carbohydrate. Exp Hematol 32(12):1146–1155

    Article  CAS  PubMed  Google Scholar 

  • European Medicines Agency (2004) NeoRecormon. Scientific Discussion. EMEA:1–14

    Google Scholar 

  • European Medicines Agency (2007) Mircera. Scientific Discussion. EMEA:1–50

    Google Scholar 

  • Fisher LM (1991) Stamina-building drug linked to athletes’ deaths. NY Times 19:22

    Google Scholar 

  • Foote MA (2003) Studies of erythropoiesis and the discovery and cloning of recombinant human erythropoietin. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Franke WW, Heid H (2006) Pitfalls, errors and risks of false-positive results in urinary EPO drug tests. Clin Chim Acta 373(1–2):189–190

    Article  CAS  PubMed  Google Scholar 

  • Gaudard A et al (2003) Drugs for increasing oxygen and their potential use in doping: a review. Sports Med 33(3):187–212

    Article  PubMed  Google Scholar 

  • Giménez E et al (2007) Towards a reliable molecular mass determination of intact glycoproteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 21(16):2555–2563

    Article  CAS  PubMed  Google Scholar 

  • Gore C et al (2003) Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88(3):333–344

    PubMed  Google Scholar 

  • Groleau PE et al (2008) Low LC-MS/MS detection of glycopeptides released from pmol levels of recombinant erythropoietin using nanoflow HPLC-chip electrospray ionization. J Mass Spectrom 43(7):924–935

    Article  CAS  PubMed  Google Scholar 

  • Guan F et al (2007) LC-MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin alpha in equine plasma. Anal Chem 79(12):4627–4635

    Article  CAS  PubMed  Google Scholar 

  • Guan F et al (2008) Differentiation and identification of recombinant human erythropoietin and darbepoetin alfa in equine plasma by LC-MS/MS for doping control. Anal Chem 80(10):3811–3817

    Article  CAS  PubMed  Google Scholar 

  • Heatherington AC (2003) Clinical pharmacokintetic properties of rHuEPO: a review. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Hokke CH et al (1995) Structural analysis of the sialylated N- and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Sialylation patterns and branch location of dimeric N-acetyllactosamine units. Eur J Biochem 228(3):981–1008

    Article  CAS  PubMed  Google Scholar 

  • Imai N et al (1990) Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin. J Biochem 107(3):352–359

    CAS  PubMed  Google Scholar 

  • Israels GL, Israels ED (2003) Erythropoiesis: an overview. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Itoh S et al (2002) Simultaneous microanalysis of N-linked oligosaccharides in a glycoprotein using microbore graphitized carbon column liquid chromatography–mass spectrometry. J Chromatogr A 968(1–2):89–100

    Article  CAS  PubMed  Google Scholar 

  • Jelkmann W (2003) Biochemistry and assay of erythropoietin. In: Jelkmann W (ed) Erythropoietin: Molecular biology and clinical use, 1st edn. F.P. Graham Publishing Co., Johnson City

    Google Scholar 

  • Jelkmann W (2007a) Control of erythropoietin gene expression and its use in medicine. Methods Enzymol 435:179–197

    Article  CAS  PubMed  Google Scholar 

  • Jelkmann W (2007b) Erythropoietin after a century of research: younger than ever. Eur J Haematol 78(3):183–205

    Article  CAS  PubMed  Google Scholar 

  • Jelkmann W (2007c) Novel erythropoietic agents: a threat to sportsmanship. Medicina Sportiva 11(2):32–42

    Article  Google Scholar 

  • Jelkmann W (2008) Developments in the therapeutic use of erythropoiesis stimulating agents. Br J Haematol 141(3):287–297

    Article  CAS  PubMed  Google Scholar 

  • Kanazawa K et al (1999) Establishment of a method for mapping of N-linked oligosaccharides and its use to analyze industrially produced recombinant erythropoietin. Biol Pharm Bull 22(4):339–346

    CAS  PubMed  Google Scholar 

  • Kanstrup IL, Ekblum B (1984) Blood volume and hemoglobin concentration as determinants of maximal aerobic power. Med Sci Sprots Exerc 16:256–262

    CAS  Google Scholar 

  • Kawasaki N et al (1999) Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry. Anal Biochem 269(2):297–303

    Article  CAS  PubMed  Google Scholar 

  • Kawasaki N et al (2000) Application of liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin. Anal Biochem 285(1):82–91

    Article  CAS  PubMed  Google Scholar 

  • Kawasaki N et al (2001) Structural analysis of sulfated N-linked oligosaccharides in erythropoietin. Glycobiology 11(12):1043–1049

    Article  CAS  PubMed  Google Scholar 

  • Kawasaki N et al (2002) Usefulness of sugar mapping by liquid chromatography/mass spectrometry in comparability assessments of glycoprotein products. Biologicals 30(2):113–123

    Article  CAS  PubMed  Google Scholar 

  • Kazlauskas R et al (2002) Strategies for rHuEPO detection in sport. Clin J Sport Med 12(4):229–235

    Article  PubMed  Google Scholar 

  • Kearns CF et al (2000) Cross reactivity between human erythropoietin antibody and horse erythropoietin. Electrophoresis 21(8):1454–1457

    Article  CAS  PubMed  Google Scholar 

  • Khan A, Baker MS (2007) Non-specific binding of monoclonal human erythropoietin antibody AE7A5 to Escherichia coli and Saccharomyces cerevisiae proteins. Clin Chim Acta 379(1–2):173–175

    Article  CAS  PubMed  Google Scholar 

  • Khan A et al (2005) New urinary EPO drug testing method using two-dimensional gel electrophoresis. Clin Chim Acta 358(1–2):119–130

    Article  CAS  PubMed  Google Scholar 

  • Kohler M et al (2008) Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Int J Sports Med 29(1):1–6

    Article  CAS  PubMed  Google Scholar 

  • Kung CK, Goldwasser E (1997) A probable conformational difference between recombinant and urinary erythropoietins. Proteins 28(1):94–98

    Article  CAS  PubMed  Google Scholar 

  • La Merie (2008) Erythropoietins: the shift from biosimilars to “more for less” ESAs. http://www.lamerie.com/press-room/erythropoietins-biosimilars-esas.html. Cited 17 August 2008

  • Lage JM et al (2002) Cyclist’s doping associated with cerebral sinus thrombosis. Neurology 58(4):665

    PubMed  Google Scholar 

  • Lamon S et al (2007a) Detection window of Darbepoetin-alpha following one single subcutaneous injection. Clin Chim Acta 379(1–2):145–149

    Article  CAS  PubMed  Google Scholar 

  • Lamon S et al (2007b) Possible origins of undetectable EPO in urine samples. Clin Chim Acta 385(1–2):61–66

    Article  CAS  PubMed  Google Scholar 

  • Lasne F (2001) Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. J Immunol Methods 253(1–2):125–131

    Article  CAS  PubMed  Google Scholar 

  • Lasne F (2003) Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J Immunol Methods 276(1–2):223–226

    Article  CAS  PubMed  Google Scholar 

  • Lasne F (2006) No doubt about the validity of the urine test for detection of recombinant human erythropoietin. Blood 108(5):1778–1779

    Article  CAS  PubMed  Google Scholar 

  • Lasne F, de Ceaurriz J (2000) No doubt about the validity of the urine test for detection of recombinant human erythropoietin. Recombinant erythropietin in urine. Nature 405:635

    Article  CAS  PubMed  Google Scholar 

  • Lasne F et al (2002) Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem 311(2):119–126

    Article  CAS  PubMed  Google Scholar 

  • Lasne F et al (2005) Detection of recombinant epoetin and darbepoetin alpha after subcutaneous administration in the horse. J Anal Toxicol 29(8):835–837

    CAS  PubMed  Google Scholar 

  • Lasne F et al (2007a) Isoelectric profiles of human erythropoietin are different in serum and urine. Int J Biol Macromol 41:354–357

    Article  CAS  PubMed  Google Scholar 

  • Lasne F et al (2007b) Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis. Electrophoresis 28(12):1875–1881

    Article  CAS  PubMed  Google Scholar 

  • Lin FK et al (1985) Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 82:7580–7582

    Article  CAS  PubMed  Google Scholar 

  • Linsley KB et al (1994) Applications of electrospray mass spectrometry to erythropoietin N- and O-linked glycans. Anal Biochem 219(2):207–217

    Article  CAS  PubMed  Google Scholar 

  • Llop E et al (2007) Evaluation of protein N-glycosylation in 2-DE: Erythropoietin as a study case. Proteomics 7(23):4278–4291

    Article  CAS  PubMed  Google Scholar 

  • Lönnberg M, Carlsson J (2000) Membrane assisted isoform immunoassay. A rapid method for the separation and determination of protein isoforms in an integrated immunoassay. J Immunol Methods 246(1–2):25–36

    Article  PubMed  Google Scholar 

  • Lönnberg M, Carlsson J (2001a) Quantitative detection in the attomole range for immunochromatographic tests by means of a flatbed scanner. Anal Biochem 293(2):224–231

    Article  CAS  PubMed  Google Scholar 

  • Lönnberg M, Carlsson J (2001b) Chromatographic performance of a thin microporous bed of nitrocellulose. J Chromatogr B Biomed Sci Appl 763(1–2):107–120

    Article  PubMed  Google Scholar 

  • Lönnberg M, Carlsson J (2006) Lab-on-a-chip technology for determination of protein isoform profiles. J Chromatogr A 1127(1–2):175–182

    Article  CAS  PubMed  Google Scholar 

  • Macdougall IC (2001) An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 16(3):14–21

    CAS  PubMed  Google Scholar 

  • Macdougall IC (2003) Use of recombinant erythropoietins in the setting of renal disease. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Masuda S et al (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269(30):19488–19493

    CAS  PubMed  Google Scholar 

  • Miyake T et al (1977) Purification of human erythropoietin. J Biol Chem 252:5558–5564

    CAS  PubMed  Google Scholar 

  • Mo W et al (1998) Structural analysis of oligosaccharides derivatized with 4-aminobenzoic acid 2-(diethylamino) ethyl ester by matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 70(21):4520–4526

    Article  CAS  PubMed  Google Scholar 

  • Molineux G (2003) Biology of erythropoietin. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Morkeberg J et al (2007) Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation. Med Sci Sports Exerc 39(10):1742–1747

    Article  CAS  PubMed  Google Scholar 

  • Neusüss C et al (2005) Glycoform characterization of intact erythropoietin by capillary electrophoresis-electrospray-time of flight-mass spectrometry. Electrophoresis 6(7–8):1442–1450

    Article  CAS  Google Scholar 

  • Nimtz M et al (1993) Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells. Eur J Biochem 213(1):39–56

    Article  CAS  PubMed  Google Scholar 

  • Nimtz M et al (1995) Identification and structural characterization of a mannose-6-phosphate containing oligomannosidic N-glycan from human erythropoietin secreted by recombinant BHK-21 cells. FEBS Lett 365(2–3):203–208

    Article  CAS  PubMed  Google Scholar 

  • Ohta M et al (2001) Selective glycopeptide mapping of erythropoietin by on-line high-performance liquid chromatography–electrospray ionization mass spectrometry. J Chromatogr A 910(1):1–11

    Google Scholar 

  • Ohta M et al (2002) Usefulness of glycopeptide mapping by liquid chromatography/mass spectrometry in comparability assessment of glycoprotein products. Biologicals 30(3):235–244

    Article  CAS  PubMed  Google Scholar 

  • Organization WH (2006) International nonproprietary names (INN) for biological and biotechnological substances. INN Working Document 05(179):1–29

    Google Scholar 

  • Osslund T, Syed R (2003) Structural basis for the signal transduction of erythropoietin. In: Molineux G, Foote MA, Elliott SG (eds) Erythropoietins and erythropoiesis, 1st edn. Birkhäuser Verlag, Basel

    Google Scholar 

  • Overbay DK, Manley HJ (2002) Darbepoetin-alpha: a review of the literature. Pharmacotherapy 22(7):889–897

    Article  CAS  PubMed  Google Scholar 

  • Parisotto R et al (2000a) A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85(6):564–572

    CAS  PubMed  Google Scholar 

  • Parisotto R et al (2000b) Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes. Int J Sports Med 21(7):471–479

    Article  CAS  PubMed  Google Scholar 

  • Parisotto R et al (2001) Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 86(2):128–137

    CAS  PubMed  Google Scholar 

  • Pascual JA et al (2004) Recombinant erythropoietin and analogues: a challenge for doping control. Ther Drug Monit 26(2):175–179

    Article  CAS  PubMed  Google Scholar 

  • Philo JS et al (1996) Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: One high-affinity and one low-affinity interaction. Biochemistry 35:1681–1691

    Article  CAS  PubMed  Google Scholar 

  • Rabin OP et al (2006) New urinary EPO drug testing method using two-dimensional gel electrophoresis. Clin Chim Acta 373(1–2):186–187

    Article  CAS  PubMed  Google Scholar 

  • Rahbek-Nielsen H et al (1997) Glycopeptide profiling of human urinary erythropoietin by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 32(9):948–958

    Article  CAS  PubMed  Google Scholar 

  • Recny MA et al (1987) Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. J Biol Chem 262(35):17156–17163

    CAS  PubMed  Google Scholar 

  • Reichel C (2007) Identification of zinc-alpha-2-glycoprotein binding to clone AE7A5 anti-human EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS. In: Schänzer et al (ed) Recent advances in doping analysis (15). Sportverlag Strauss, Cologne

    Google Scholar 

  • Reichel C (2008) SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Manfred Donike Workshop (oral presentation) – 26th Cologne Workshop in Doping Analysis Cologne, Germany. February 24–29, 2008

    Google Scholar 

  • Reichel C et al (2006) Improvement in the background correction of EPO IEF images. In: Schänzer et al (ed) Recent advances in doping analysis (14). Sportverlag Strauss, Cologne

    Google Scholar 

  • Reichel C et al (2009) SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Drug Test Anal 1:43–50

    Article  CAS  PubMed  Google Scholar 

  • Rice KG et al (1992) Quantitative mapping of the N-linked sialyloligosaccharides of recombinant erythropoietin: combination of direct high-performance anion-exchange chromatography and 2-aminopyridine derivatization. Anal Biochem 206(2):278–287

    Article  CAS  PubMed  Google Scholar 

  • Robinson N et al (2006) Erythropoietin and blood doping. Br J Sports Med 40(Suppl 1):i30–i34

    Article  PubMed  Google Scholar 

  • Robinson N et al (2007) Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes. Haematologica 92(8):1143–1144

    Article  PubMed  Google Scholar 

  • Rush RS et al (1995) Microheterogeneity of erythropoietin carbohydrate structure. Anal Chem 67(8):1442–1452

    Article  CAS  PubMed  Google Scholar 

  • Russel G et al (2002) Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Eur J Appl Physiol 86:442–449

    Article  CAS  Google Scholar 

  • Sanz-Nebot V et al (2003) Separation of recombinant human erythropoietin glycoforms by capillary electrophoresis using volatile electrolytes. Assessment of mass spectrometry for the characterization of erythropoietin glycoforms. Anal Chem 75(19):5220–5229

    Article  CAS  PubMed  Google Scholar 

  • Sasaki H et al (1987) Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem 262(25):12059–12076

    CAS  PubMed  Google Scholar 

  • Sasaki H et al (1988) Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry. Biochemistry 27(23):8618–8626

    Article  CAS  PubMed  Google Scholar 

  • Schellekens H (2004) Biosimilar epoetins: how similar are they? EHLP Journal 3:43–47

    Google Scholar 

  • Schellekens H (2005) Follow-on biologics: challenges of the “next generation”. Nephrol Dial Transplant 4:31–36

    Google Scholar 

  • Schlags W et al (2002) Two-dimensional electrophoresis of recombinant human erythropoietin: a future method for the European Pharmacopoeia? Proteomics 2(6):679–682

    Article  CAS  PubMed  Google Scholar 

  • Segura J et al (2007) Procedures for monitoring recombinant erythropoietin and analogues in doping control. Anal Bioanal Chem 388(7):1521–1529

    Article  CAS  PubMed  Google Scholar 

  • Sharpe K et al (2002) Development of reference ranges in elite athletes for markers of altered erythropoiesis. Haematologica 87(12):1248–1257

    PubMed  Google Scholar 

  • Sharpe K et al (2006) A third generation approach to detect erythropoietin abuse in athletes. Haematologica 91(3):356–363

    CAS  PubMed  Google Scholar 

  • Sherwood JB et al (1988) The heterogeneity of circulating human serum erythropoietin. Endocrinology 122:1472–1477

    Article  CAS  PubMed  Google Scholar 

  • Siegmund-Schultze N (2007) Doping: Jede Diagnose kann geschönt werden. Dtsch Arztebl. http://www.aerzteblatt.de/v4/archiv/artikel.asp?src = heft&id = 57223. Cited 16 September 2008

  • Singh AK, Gupta S (2007) Analysis of recombinant human erythropoietin and darbepoietin in spiked plasma. Proteomics 1(7):625–716

    Google Scholar 

  • Skibeli V et al (2001) Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98(13):3626–3634

    Article  CAS  PubMed  Google Scholar 

  • Skibeli V et al (2003) Immunomagnetic extraction as a tool for the analysis of human serum erythropoietin. DYNALogue 1:13–15

    Google Scholar 

  • Sottani C et al (1997) Matrix performance in matrix-assisted laser desorption/ionization for molecular weight determination in sialyl and non-sialyl oligosaccharide proteins. Rapid Commun Mass Spectrom 11(8):907–913

    Article  CAS  PubMed  Google Scholar 

  • Stanley SM, Poljak A (2003) Matrix-assisted laser-desorption time-of flight ionisation and high-performance liquid chromatography-electrospray ionisation mass spectral analyses of two glycosylated recombinant epoetins. J Chromatogr B Analyt Technol Biomed Life Sci 785(2):205–218

    Article  CAS  PubMed  Google Scholar 

  • Stead RB et al (2006) Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers. Blood 108(6):1830–1834

    Article  CAS  PubMed  Google Scholar 

  • Stolc S, Bajla I (2006) Improvement of band segmentation in Epo images via column shift transformation with cost functions. Med Biol Eng Comput 44(4):257–274

    Article  CAS  PubMed  Google Scholar 

  • Storring PL et al (1998) Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties. Br J Haematol 100(1):79–89

    Article  CAS  PubMed  Google Scholar 

  • Stübiger G et al (2005a) Characterization of N- and O-glycopeptides of recombinant human erythropoietins as potential biomarkers for doping analysis by means of microscale sample purification combined with MALDI-TOF and quadrupole IT/RTOF mass spectrometry. J Sep Sci 28(14):1764–1778

    Article  PubMed  Google Scholar 

  • Stübiger G et al (2005b) Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 19(5):728–742

    Article  CAS  PubMed  Google Scholar 

  • Syed RS et al (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395:511–516

    Article  CAS  PubMed  Google Scholar 

  • Sytkowski AJ (2004) Erythropoietin. Blood, brain and beyond. Wiley-VCH, Weinheim, p 63, 192

    Google Scholar 

  • Sytkowski AJ, Fisher JW (1985) Isolation and characterization of an anti-peptide monoclonal antibody to human erythropoietin. J Biol Chem 260(27):14727–14731

    CAS  PubMed  Google Scholar 

  • Takegawa Y et al (2008) Profiling of N- and O-glycopeptides of erythropoietin by capillary zwitterionic type of hydrophilic interaction chromatography/electrospray ionization mass spectrometry. J Sep Sci 31(9):1585–1593

    Article  CAS  PubMed  Google Scholar 

  • Tam RC et al (1991) Comparisons of human, rat and mouse erythropoietins by isoelectric focusing: differences between serum and urinary erythropoietins. Br J Haematol 79(3):504–511

    Article  CAS  PubMed  Google Scholar 

  • Thevis M et al (2007) Proteases in doping control analysis. Int J Sports Med 28(7):545–549

    Article  CAS  PubMed  Google Scholar 

  • Tsuda E et al (1988) Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins. Biochemistry 27(15):5646–5654

    Article  CAS  PubMed  Google Scholar 

  • Watson E, Yao F (1993) Capillary electrophoretic separation of human recombinant erythropoietin (r-HuEPO) glycoforms. Anal Biochem 210(2):389–393

    Article  CAS  PubMed  Google Scholar 

  • Westermeier R (2004) Electrophoresis in practice: a guide to methods and applications of DNA and protein separations. Wiley-VCH, Weinheim

    Google Scholar 

  • Wide L, Bengtsson C (1990) Molecular charge heterogeneity of human serum erythropoietin. Br J Haematol 76(1):121–127

    Article  CAS  PubMed  Google Scholar 

  • Wide L et al (1995) Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 27(11):1569–1576

    CAS  PubMed  Google Scholar 

  • World Anti-Doping Agency (2007) Harmonization of the method for the identification of epoetin alfa and beta (rEPO) and darbepoetin alfa (NESP) by IEF-double blotting and chemiluminescent detection. http://www.wada-ama.org/rtecontent/document/td2007epo_en.pdf. Cited 16 August 2008

  • World Anti-Doping Agency (2008) The World Anti-Doping Code, 2008 Prohibited List http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf. Cited 16 August 2008

  • Yu B et al (2005) Ionene-dynamically coated capillary for analysis of urinary and recombinant human erythropoietin by capillary electrophoresis and online electrospray ionization mass spectrometry. J Sep Sci 28(17):2390–2400

    Article  CAS  PubMed  Google Scholar 

  • Yuan J et al (2005) Isotope tag method for quantitative analysis of carbohydrates by liquid chromatography-mass spectrometry. J Chromatogr A 1067(1–2):145–152

    Article  CAS  PubMed  Google Scholar 

  • Yuen CT et al (2003) Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures. Br J Haematol 121(3):511–526

    Article  CAS  PubMed  Google Scholar 

  • Zhou GH et al (1998) Application of capillary electrophoresis, liquid chromatography, electrospray-mass spectrometry and matrix-assisted laser desorption/ionization – time of flight – mass spectrometry to the characterization of recombinant human erythropoietin. Electrophoresis 19(13):2348–2355

    Article  CAS  PubMed  Google Scholar 

  • Zotter H et al (2004) Abnormally high serum ferritin levels among professional road cyclists. Br J Sports Med 38(6):704–708

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Dr. T. Stockner (Austrian Research Centers GmbH – ARC) for modeling of the EPO–EPO-Receptor complex.

Author information

Authors and Affiliations

  1. Austrian Research Centers GmbH – ARC, Doping Control Laboratory, A-2444, Seibersdorf, Austria

    Christian Reichel

Authors
  1. Christian Reichel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Günter Gmeiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Reichel .

Editor information

Editors and Affiliations

  1. Sportbiochemie Dresden, Institut für Dopinganalytik und, Dresdner Straße 12, Kreischa, 01731, Germany

    Detlef Thieme

  2. Gamle Trondheimsvei 39, Hagan, 1481, Norway

    Peter Hemmersbach

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Reichel, C., Gmeiner, G. (2010). Erythropoietin and Analogs. In: Thieme, D., Hemmersbach, P. (eds) Doping in Sports: Biochemical Principles, Effects and Analysis. Handbook of Experimental Pharmacology, vol 195. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79088-4_12

Download citation

Publish with us

Policies and ethics

Search

Navigation